FORWARD PHARMA A/S-ADR (FWP)
US34986J2042 - ADR
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 70.77M | 79.10M | 77.60M | 82.50M | 109.60M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 140.00K | 300.00K | 300.00K | 400.00K | 900.00K | |||
| Other Current Assets | 492.00K | 300.00K | 300.00K | 300.00K | 500.00K | |||
| Total Current Assets | 71.40M | 79.70M | 78.20M | 83.30M | 111.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Assets | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 71.41M | 79.70M | 78.20M | 83.30M | 111.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 538.00K | 600.00K | 500.00K | 600.00K | 13.00M | |||
| Accounts Payable | 70.00K | 500.00K | 100.00K | 400.00K | 1.20M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 100.00K | 7.00M | |||
| Total Current Liabilities | 608.00K | 1.10M | 600.00K | 1.10M | 21.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 608.00K | 1.10M | 600.00K | 1.10M | 21.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -16.72M | -14.80M | -8.40M | -5.70M | -2.40M | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 157.00K | 200.00K | 200.00K | 200.00K | 200.00K | |||
| Other Shareholders' Equity | 87.36M | 93.30M | 85.80M | 87.70M | 91.90M | |||
| Shares Outstanding | 98.26M | 95.10M | 13.60M | 13.60M | 13.50M | |||
| Tangible Book Value per Share | 0.72 | 0.83 | 5.71 | 6.04 | 6.64 | |||
| Total Shareholders' Equity | 70.80M | 78.60M | 77.60M | 82.20M | 89.70M | |||
| TOTAL LIABILITIES AND EQUITY | 71.41M | 79.70M | 78.20M | 83.30M | 111.00M | |||
| Statistics | ||||||||
| Current Ratio | 117.44 | 72.45 | 130.33 | 75.73 | 5.21 | |||
| Return On Assets (ROA) | -2.65% | -8.03% | -5.37% | -10.44% | 826.22% | |||
| Return On Equity (ROE) | -2.67% | -8.14% | -5.41% | -10.58% | 1022.41% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 1045.76% | |||
All data in USD